v3.25.1
LOSS PER SHARE (Details Narrative) - shares
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Common stock excercise warrant shares 10,000 10,000
Common Stock [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Stock issued upon conversion, shares 5,234,064 1,790,607